Neoadjuvant treatment of pancreatic ductal adenocarcinoma

被引：1

作者：

Kosma, Katharina ^{[1
]}

Thalhammer, Sabine ^{[1
]}

Gruenberger, Thomas ^{[1
]}

机构：

[1] Clin Favoriten, Dept Surg, Hepatopancreatobiliary Ctr, Hlth Network Vienna, Kundratstr 3, A-1100 Vienna, Austria

来源：

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2022年 / 15卷 / 03期

关键词：

Borderline resectable pancreatic cancer; Resectable pancreatic cancer; Neoadjuvant; Induction therapy; Surgery; Overall survival; ADJUVANT CHEMOTHERAPY; UPFRONT SURGERY; CANCER; THERAPY; CHEMORADIATION; COMPLICATIONS;

D O I：

10.1007/s12254-022-00832-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Neoadjuvant therapy in resectable and borderline resectable pancreatic cancer is the subject of several ongoing randomized controlled trials (RCTs). Retrospective studies and completed RCTs favor the use of neoadjuvant therapy in pancreatic cancer. Yet, the optimal chemotherapy regimen has not been defined. The objective of this report is to provide a review of currently available study data of neoadjuvant therapy in pancreatic cancer.

引用

页码：219 / 223

页数：5

共 33 条

[21] Neoadjuvant Therapy Followed by Resection Versus Upfront Resection for Resectable Pancreatic Cancer: A Propensity Score Matched Analysis [J].

Mokdad, Ali A. ;

Minter, Rebecca M. ;

Zhu, Hong ;

Augustine, Mathew M. ;

Porembka, Matthew R. ;

Wang, Sam C. ;

Yopp, Adam C. ;

Mansour, John C. ;

Choti, Michael A. ;

Polanco, Patricio M. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05) :515-+

[22] The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma [J].

Rhee, Hyungjin ;

Park, Mi Suk .

KOREAN JOURNAL OF RADIOLOGY, 2021, 22 (01) :23-40

[23] Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) [J].

Schwarz, Lilian ;

Vernerey, Dewi ;

Bachet, Jean-Baptiste ;

Tuech, Jean-Jacques ;

Portales, Fabienne ;

Michel, Pierre ;

Cunha, Antonio Sa .

BMC CANCER, 2018, 18

[24] Cancer Statistics, 2021 [J].

Siegel, Rebecca L. ;

Miller, Kimberly D. ;

Fuchs, Hannah E. ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (01) :7-33

[25] Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis [J].

Sugimoto, Motokazu ;

Takahashi, Naoki ;

Farnell, Michael B. ;

Smyrk, Thomas C. ;

Truty, Mark J. ;

Nagorney, David M. ;

Smoot, Rory L. ;

Chari, Suresh T. ;

Carter, Rickey E. ;

Kendrick, Michael L. .

JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (06) :976-984

[26] Pancreatic Adenocarcinoma, Version 2.2017 [J].

Tempero, Margaret A. ;

Malafa, Mokenge P. ;

Al-Hawary, Mahmoud ;

Asbun, Horacio ;

Bain, Andrew ;

Behrman, Stephen W. ;

Benson, Al B., III ;

Binder, Ellen ;

Cardin, Dana B. ;

Cha, Charles ;

Chiorean, E. Gabriela ;

Chung, Vincent ;

Czito, Brian ;

Dillhoff, Mary ;

Dotan, Efrat ;

Ferrone, Cristina R. ;

Hardacre, Jeffrey ;

Hawkins, William G. ;

Herman, Joseph ;

Ko, Andrew H. ;

Komanduri, Srinadh ;

Koong, Albert ;

LoConte, Noelle ;

Lowy, Andrew M. ;

Moravek, Cassadie ;

Nakakura, Eric K. ;

O'Reilly, Eileen M. ;

Obando, Jorge ;

Reddy, Sushanth ;

Scaife, Courtney ;

Thayer, Sarah ;

Weekes, Colin D. ;

Wolff, Robert A. ;

Wolpin, Brian M. ;

Burns, Jennifer ;

Darlow, Susan .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (08) :1028-+

[27] Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival [J].

Tzeng, Ching-Wei D. ;

Cao, Hop S. Tran ;

Lee, Jeffrey E. ;

Pisters, Peter W. T. ;

Varadhachary, Gauri R. ;

Wolff, Robert A. ;

Abbruzzese, James L. ;

Crane, Christopher H. ;

Evans, Douglas B. ;

Wang, Huamin ;

Abbott, Daniel E. ;

Vauthey, Jean-Nicolas ;

Aloia, Thomas A. ;

Fleming, Jason B. ;

Katz, Matthew H. G. .

JOURNAL OF GASTROINTESTINAL SURGERY, 2014, 18 (01) :16-24

[28] Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials [J].

van Dam, Jacob L. ;

Janssen, Quisette P. ;

Besselink, Marc G. ;

Homs, Marjolein Y., V ;

van Santvoort, Hjalmar C. ;

van Tienhoven, Geertjan ;

de Wilde, Roeland F. ;

Wilmink, Johanna W. ;

van Eijck, Casper H. J. ;

Koerkamp, Bas Groot .

EUROPEAN JOURNAL OF CANCER, 2022, 160 :140-149

[29] Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer [J].

Versteijne, E. ;

Vogel, J. A. ;

Besselink, M. G. ;

Busch, O. R. C. ;

Wilmink, J. W. ;

Daams, J. G. ;

van Eijck, C. H. J. ;

Koerkamp, B. Groot ;

Rasch, C. R. N. ;

van Tienhoven, G. .

BRITISH JOURNAL OF SURGERY, 2018, 105 (08) :946-958

[30] Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial [J].

Versteijne, Eva ;

van Dam, Jacob L. ;

Suker, Mustafa ;

Janssen, Quisette P. ;

Groothuis, Karin ;

Akkermans-Vogelaar, Janine M. ;

Besselink, Marc G. ;

Bonsing, Bert A. ;

Buijsen, Jeroen ;

Busch, Olivier R. ;

Creemers, Geert-Jan M. ;

van Dam, Ronald M. ;

Eskens, Ferry A. L. M. ;

Festen, Sebastiaan ;

de Groot, Jan Willem B. ;

Koerkamp, Bas Groot ;

de Hingh, Ignace H. ;

Homs, Marjolein Y., V ;

van Hooft, Jeanin E. ;

Kerver, Emile D. ;

Luelmo, Saskia A. C. ;

Neelis, Karen J. ;

Nuyttens, Joost ;

Paardekooper, Gabriel M. R. M. ;

Patijn, Gijs A. ;

van der Sangen, Maurice J. C. ;

de Vos-Geelen, Judith ;

Wilmink, Johanna W. ;

Zwinderman, Aeilko H. ;

Punt, Cornelis J. ;

van Tienhoven, Geertjan ;

van Eijck, Casper H. J. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (11) :1220-+

← 1 2 3 4 →